The following is a summary of “Long-term effectiveness of aripiprazole once monthly on functioning and quality of life in schizophrenia: results of year 2 of the ReLiAM study,” published in the ...
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
Researchers led by the University of California, Irvine are the first to reveal how two neural circuits located in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback